标题
Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock
作者
关键词
-
出版物
Frontiers in Neuroscience
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-09-18
DOI
10.3389/fnins.2020.580179
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery
- (2020) K. L. Pietersz et al. GENE THERAPY
- Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients
- (2019) Raygene Martier et al. Molecular Therapy-Nucleic Acids
- Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity
- (2019) Yong-Jie Zhang et al. SCIENCE
- Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
- (2019) Eloise Hudry et al. NEURON
- C9orf72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism
- (2019) Yang Liu et al. Autophagy
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- In-depth characterization of a Mifepristone regulated expression system for AAV5-mediated gene therapy in the liver
- (2019) Jolanda M. Liefhebber et al. Molecular Therapy-Methods & Clinical Development
- Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
- (2019) Raygene Martier et al. Molecular Therapy-Nucleic Acids
- AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes
- (2019) Sonay Keskin et al. Molecular Therapy-Methods & Clinical Development
- Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
- (2019) Raygene Martier et al. Molecular Therapy-Methods & Clinical Development
- MicroRNAs as Clinical Biomarkers and Therapeutic Tools in Perioperative Medicine
- (2018) Simone Kreth et al. ANESTHESIA AND ANALGESIA
- Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Exon-skipping advances for Duchenne muscular dystrophy
- (2018) Lucía Echevarría et al. HUMAN MOLECULAR GENETICS
- Machado-Joseph disease / Spinocerebellar ataxia type 3:lessons from disease pathogenesis and clues into therapy
- (2018) Carlos Matos et al. JOURNAL OF NEUROCHEMISTRY
- Amyotrophic Lateral Sclerosis: An Update for 2018
- (2018) Björn Oskarsson et al. MAYO CLINIC PROCEEDINGS
- Update on phase 1/2 clinical trials for MPS I and MPS II using ZFN-mediated in vivo genome editing
- (2018) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
- (2018) Kanut Laoharawee et al. MOLECULAR THERAPY
- Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
- (2018) Jana Miniarikova et al. MOLECULAR THERAPY
- AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model
- (2018) Melvin M. Evers et al. MOLECULAR THERAPY
- First in vivo human genome editing trial
- (2018) NATURE BIOTECHNOLOGY
- Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
- (2018) Yingxiao Shi et al. NATURE MEDICINE
- CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells
- (2018) Shuming Ouyang et al. STEM CELLS AND DEVELOPMENT
- Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease
- (2018) Michael S. Rafii et al. JAMA Neurology
- AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
- (2018) Jonathan B. Rosenberg et al. Human Gene Therapy Clinical Development
- Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free “GeneSwitch” vector
- (2018) Shi Cheng et al. EXPERIMENTAL NEUROLOGY
- A brief account of viral vectors and their promise for gene therapy
- (2017) M Finer et al. GENE THERAPY
- MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain
- (2017) L Samaranch et al. GENE THERAPY
- AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
- (2017) J Miniarikova et al. GENE THERAPY
- Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future
- (2017) Françoise Piguet et al. HUMAN GENE THERAPY
- TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway
- (2017) Diane Moujalled et al. HUMAN MOLECULAR GENETICS
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery
- (2017) Chaitanya R. Joshi et al. Journal of Neuroimmune Pharmacology
- Polyglutamine tracts regulate beclin 1-dependent autophagy
- (2017) Avraham Ashkenazi et al. NATURE
- Emptying the stores: lysosomal diseases and therapeutic strategies
- (2017) Frances M. Platt NATURE REVIEWS DRUG DISCOVERY
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- Polyglutamine spinocerebellar ataxias — from genes to potential treatments
- (2017) Henry L. Paulson et al. NATURE REVIEWS NEUROSCIENCE
- AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: end-of-Study event free survival and achievement of developmental milestones
- (2017) J. Mendell et al. NEUROMUSCULAR DISORDERS
- Dicer-independent processing of small RNA duplexes: mechanistic insights and applications
- (2017) Elena Herrera-Carrillo et al. NUCLEIC ACIDS RESEARCH
- Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
- (2017) Francesco Puzzo et al. Science Translational Medicine
- Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
- (2017) David W. Morgens et al. Nature Communications
- Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
- (2017) Vijay Kumar et al. Frontiers in Neuroscience
- Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
- (2017) Lodewijk J.A. Toonen et al. Molecular Therapy-Nucleic Acids
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
- (2017) Sang-oh Han et al. Molecular Therapy-Methods & Clinical Development
- Protein misfolding in neurodegenerative diseases: implications and strategies
- (2017) Patrick Sweeney et al. Translational Neurodegeneration
- The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
- (2017) Andreas Neueder et al. Scientific Reports
- There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
- (2016) Aaron D. Gitler et al. BRAIN RESEARCH
- Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
- (2016) Michaël Hocquemiller et al. HUMAN GENE THERAPY
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
- (2016) Joana Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)
- (2016) M. E. Bosch et al. JOURNAL OF NEUROSCIENCE
- 258. Phase I/IIa Study of TT-034, a DNA-Directed RNA Interference (ddRNAi) Agent Delivered as a Single Administration for the Treatment of Subjects with Chronic Hepatitis C Virus (HCV)
- (2016) Keyur Patel et al. MOLECULAR THERAPY
- 567. CRISPR-Cas9 Mediated Gene Editing in a Monogenic Form of Alzheimer's Disease
- (2016) Bence Gyorgy et al. MOLECULAR THERAPY
- Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
- (2016) Benjamin E Deverman et al. NATURE BIOTECHNOLOGY
- The Prevalence of Huntington's Disease
- (2016) Michael D. Rawlins et al. NEUROEPIDEMIOLOGY
- Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population
- (2016) Mfon E. Umoh et al. NEUROLOGY
- C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD
- (2016) Yuanjing Liu et al. NEURON
- Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
- (2016) Jie Jiang et al. NEURON
- RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery
- (2016) Walt F. Lima et al. NUCLEIC ACIDS RESEARCH
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
- (2016) Jana Miniarikova et al. Molecular Therapy-Nucleic Acids
- 395. OXB-102: An Enhanced Gene Therapy for Parkinson's Disease
- (2016) MOLECULAR THERAPY
- Antisense oligonucleotides in therapy for neurodegenerative disorders
- (2015) Melvin M. Evers et al. ADVANCED DRUG DELIVERY REVIEWS
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits
- (2015) Max Koppers et al. ANNALS OF NEUROLOGY
- A large animal model of spinal muscular atrophy and correction of phenotype
- (2015) Sandra I. Duque et al. ANNALS OF NEUROLOGY
- Genetics of the neuronal ceroid lipofuscinoses (Batten disease)
- (2015) Sara E. Mole et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose–response Study in Mice and Nonhuman Primates
- (2015) Kathrin Meyer et al. MOLECULAR THERAPY
- Genome Editing Technologies: Defining a Path to Clinic
- (2015) Jacqueline Corrigan-Curay et al. MOLECULAR THERAPY
- The C9orf72 repeat expansion disrupts nucleocytoplasmic transport
- (2015) Ke Zhang et al. NATURE
- GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
- (2015) Brian D. Freibaum et al. NATURE
- Inducible in vivo genome editing with CRISPR-Cas9
- (2015) Lukas E Dow et al. NATURE BIOTECHNOLOGY
- Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS
- (2015) Ana Jovičić et al. NATURE NEUROSCIENCE
- A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
- (2015) Pawel M. Switonski et al. NEUROBIOLOGY OF DISEASE
- Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
- (2015) Owen M. Peters et al. NEURON
- C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
- (2015) Jacqueline G. O’Rourke et al. NEURON
- C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits
- (2015) J. Chew et al. SCIENCE
- Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3
- (2015) Rui Gao et al. PLoS Genetics
- The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis
- (2015) Arpita Chatterjee et al. PLoS Genetics
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
- (2015) Xiao-Hui Zhang et al. Molecular Therapy-Nucleic Acids
- Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
- (2015) Manuela Corti et al. Human Gene Therapy Clinical Development
- Risk factors for amyotrophic lateral sclerosis
- (2015) Fang Fang et al. Clinical Epidemiology
- Huntington disease
- (2015) Gillian P. Bates et al. Nature Reviews Disease Primers
- Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress
- (2014) Yong-Jie Zhang et al. ACTA NEUROPATHOLOGICA
- Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS
- (2014) Janis Bennion Callister et al. EXPERIMENTAL NEUROLOGY
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
- (2014) Rajat M. Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Adeno-Associated Virus Vectors and Neurological Gene Therapy
- (2014) David S. Ojala et al. NEUROSCIENTIST
- Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease)
- (2014) Arlene V. Drack et al. OPHTHALMIC GENETICS
- C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
- (2014) S. Mizielinska et al. SCIENCE
- Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia
- (2013) Alan Stepto et al. ACTA NEUROPATHOLOGICA
- Protein aggregation in amyotrophic lateral sclerosis
- (2013) Anna M. Blokhuis et al. ACTA NEUROPATHOLOGICA
- NCL diseases — clinical perspectives
- (2013) Angela Schulz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes
- (2013) Barbara K. Smith et al. HUMAN GENE THERAPY
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
- (2013) Melvin M. Evers et al. MOLECULAR NEUROBIOLOGY
- Toward RNAi Therapy for the Polyglutamine Disease Machado–Joseph Disease
- (2013) Maria do Carmo Costa et al. MOLECULAR THERAPY
- Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
- (2013) Emily R. Fisher et al. MOVEMENT DISORDERS
- Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis
- (2013) Matthew B. Harms et al. NEUROBIOLOGY OF AGING
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
- (2013) Christopher J. Donnelly et al. NEURON
- Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
- (2013) Luca F. R. Gebert et al. NUCLEIC ACIDS RESEARCH
- Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice
- (2013) Clévio Nóbrega et al. PLoS One
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
- (2013) Dominik F. Aschauer et al. PLoS One
- RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
- (2013) T. Zu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration
- (2013) Z. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration
- (2013) C. Lagier-Tourenne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
- (2013) D. Sareen et al. Science Translational Medicine
- Developmental neuroplasticity and the origin of neurodegenerative diseases
- (2013) Andrea T. U. Schaefers et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Mechanisms of RNA-induced toxicity in CAG repeat disorders
- (2013) R Nalavade et al. Cell Death & Disease
- Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology
- (2012) Clévio Nóbrega et al. CEREBELLUM
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Ataxin-3 Regulates Aggresome Formation of Copper-Zinc Superoxide Dismutase (SOD1) by Editing K63-linked Polyubiquitin Chains
- (2012) Hongfeng Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RNA-mediated toxicity in neurodegenerative disease
- (2012) Veronique V. Belzil et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Mouse Models of Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
- (2012) Veronica F. Colomer Gould Neurotherapeutics
- Long-Term Follow-Up After Gene Therapy for Canavan Disease
- (2012) P. Leone et al. Science Translational Medicine
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
- (2012) B. N. Chau et al. Science Translational Medicine
- Guided delivery of adeno-associated viral vectors into the primate brain
- (2011) Ernesto A. Salegio et al. ADVANCED DRUG DELIVERY REVIEWS
- FTD and ALS: A Tale of Two Diseases
- (2011) R. Ferrari et al. Current Alzheimer Research
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Alternative miRNA Biogenesis Pathways and the Interpretation of Core miRNA Pathway Mutants
- (2011) Jr-Shiuan Yang et al. MOLECULAR CELL
- Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
- (2011) Adam K Bevan et al. MOLECULAR THERAPY
- Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery
- (2011) Haiyan Fu et al. MOLECULAR THERAPY
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
- (2011) Dawn E Bowles et al. MOLECULAR THERAPY
- Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain
- (2011) R. Mark Richardson et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans
- (2010) Li-Chun Wang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Intrathecal Injection of Helper-Dependent Adenoviral Vectors Results in Long-Term Transgene Expression in Neuroependymal Cells and Neurons
- (2010) Scott Dindot et al. HUMAN GENE THERAPY
- Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery
- (2010) Adam K. Bevan et al. HUMAN MOLECULAR GENETICS
- TDP-43: A DNA and RNA binding protein with roles in neurodegenerative diseases
- (2010) Sadaf T. Warraich et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
- (2010) N Matthew Ellinwood et al. MOLECULAR THERAPY
- A dicer-independent miRNA biogenesis pathway that requires Ago catalysis
- (2010) Sihem Cheloufi et al. NATURE
- TAR DNA-binding protein 43 in neurodegenerative disease
- (2010) Alice S. Chen-Plotkin et al. Nature Reviews Neurology
- Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products
- (2010) Anabela Silva-Fernandes et al. NEUROBIOLOGY OF DISEASE
- Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies
- (2010) Felix Geser et al. NEUROPATHOLOGY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- A viral assembly factor promotes AAV2 capsid formation in the nucleolus
- (2010) F. Sonntag et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-ATG-initiated translation directed by microsatellite expansions
- (2010) T. Zu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis
- (2010) J.-S. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity
- (2010) D. Cifuentes et al. SCIENCE
- RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
- (2010) D. L. DiGiusto et al. Science Translational Medicine
- New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado–Joseph disease)
- (2009) Udo Rüb et al. CURRENT OPINION IN NEUROLOGY
- Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3
- (2009) Sokol V Todi et al. EMBO JOURNAL
- RNAi-based therapeutics-current status, challenges and prospects
- (2009) Katrin Tiemann et al. EMBO Molecular Medicine
- Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
- (2009) Joonil Jung et al. HUMAN MOLECULAR GENETICS
- Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3
- (2009) Jana Boy et al. HUMAN MOLECULAR GENETICS
- Prion-like mechanisms in neurodegenerative diseases
- (2009) Bess Frost et al. NATURE REVIEWS NEUROSCIENCE
- A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats
- (2009) Jana Boy et al. NEUROBIOLOGY OF DISEASE
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration
- (2009) J. M. Ravits et al. NEUROLOGY
- Nucleocytoplasmic Shuttling Activity of Ataxin-3
- (2009) Sandra Macedo-Ribeiro et al. PLoS One
- microRNA-122 stimulates translation of hepatitis C virus RNA
- (2008) Jura Inga Henke et al. EMBO JOURNAL
- Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis by CNS Administration of a Serotype 2 Adeno-Associated Virus Expressing CLN2 cDNA
- (2008) Stefan Worgall et al. HUMAN GENE THERAPY
- Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells
- (2008) J. Chang et al. JOURNAL OF VIROLOGY
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?
- (2008) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
- Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
- (2008) An-Hsun Chou et al. NEUROBIOLOGY OF DISEASE
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now